-
1
-
-
0032987941
-
Antitumor potential of acyclic nucleoside phosphonates
-
De Clercq E, Andrei G, Balzarini J, Hatse S, Liekens S, Naesens L, Neyts J and Snoeck R: Antitumor potential of acyclic nucleoside phosphonates. Nucleosides Nucleotides 18: 759-771, 1999. (Pubitemid 29320593)
-
(1999)
Nucleosides and Nucleotides
, vol.18
, Issue.4-5
, pp. 759-771
-
-
De Clercq, E.1
Andrei, G.2
Balzarini, J.3
Hatse, S.4
Liekens, S.5
Naesens, L.6
Neyts, J.7
Snoeck, R.8
-
2
-
-
0032555639
-
Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase delta and epsilon in vitro
-
DOI 10.1074/jbc.273.34.21966
-
Kramata P, Downey KM and Paborsky LR: Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase delta and epsilon in vitro. J Biol Chem 273: 21966-21971, 1998. (Pubitemid 28405376)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.34
, pp. 21966-21971
-
-
Kramata, P.1
Downey, K.M.2
Paborsky, L.R.3
-
3
-
-
66649100502
-
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219
-
Tsai CY, Ray AS, Tumas DB, Keating MJ, Reiser H and Plunkett W: Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219. Clin Cancer Res 15: 3760-3769, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3760-3769
-
-
Tsai, C.Y.1
Ray, A.S.2
Tumas, D.B.3
Keating, M.J.4
Reiser, H.5
Plunkett, W.6
-
4
-
-
0033567434
-
6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG)
-
6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG). Biochem Pharmacol 58: 709-714, 1999.
-
(1999)
Biochem Pharmacol
, vol.58
, pp. 709-714
-
-
Compton, M.L.1
Toole, J.J.2
Paborsky, L.R.3
-
5
-
-
0033564975
-
6-cyclopropyl-PMEDAP: A novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiprolife-rative, and differentiation-inducing properties
-
6- cyclopropyl-PMEDAP: A novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6- diaminopurine (PMEDAP) with distinct metabolic, antiprolife-rative, and differentiation-inducing properties. Biochem Pharmacol 58: 311-323, 1999.
-
(1999)
Biochem Pharmacol
, vol.58
, pp. 311-323
-
-
Hatse, S.1
Naesens, L.2
De Clercq, E.3
Balzarini, J.4
-
6
-
-
52049093225
-
GS-9219 - A novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma
-
Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne IN, Wolfgang GH, Desai M, Rhodes GR, Fridland A, Lee WA, Plunkett W, Vail D, Thamm DH, Jeraj R and Tumas DB: GS-9219 - a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma. Clin Cancer Res 14: 2824-2832, 2008.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2824-2832
-
-
Reiser, H.1
Wang, J.2
Chong, L.3
Watkins, W.J.4
Ray, A.S.5
Shibata, R.6
Birkus, G.7
Cihlar, T.8
Wu, S.9
Li, B.10
Liu, X.11
Henne, I.N.12
Wolfgang, G.H.13
Desai, M.14
Rhodes, G.R.15
Fridland, A.16
Lee, W.A.17
Plunkett, W.18
Vail, D.19
Thamm, D.H.20
Jeraj, R.21
Tumas, D.B.22
more..
-
8
-
-
0034672616
-
Interaction of guanine phosphonomethoxyalkyl derivatives with GMP kinase isoenzymes
-
Krejcova R, Horska K, Votruba I and Holy A: Interaction of guanine phosphonomethoxyalkyl derivatives with GMP kinase isoenzymes. Biochem Pharmacol 60: 1907-1913, 2000.
-
(2000)
Biochem Pharmacol
, vol.60
, pp. 1907-1913
-
-
Krejcova, R.1
Horska, K.2
Votruba, I.3
Holy, A.4
-
9
-
-
79958174504
-
Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG
-
Mertlikova-Kaiserova H, Rumlova M, Tloustova E, Prochazkova E, Holy A and Votruba I: Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG. Biochem Pharmacol 82: 131-138, 2011.
-
(2011)
Biochem Pharmacol
, vol.82
, pp. 131-138
-
-
Mertlikova-Kaiserova, H.1
Rumlova, M.2
Tloustova, E.3
Prochazkova, E.4
Holy, A.5
Votruba, I.6
-
10
-
-
0025372944
-
Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro
-
DOI 10.1016/0166-3542(90)90014-X
-
Holý A, Votruba I, Merta A, Černý J, Veselý J, Vlach J, Šedivá K, Rosenberg I, Otmar M, Hř ebabecký H, Trávníek M, Vonka V, Snoeck R and De Clercq E: Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res 13: 295-311, 1990. (Pubitemid 20223544)
-
(1990)
Antiviral Research
, vol.13
, Issue.6
, pp. 295-311
-
-
Holy, A.1
Votruba, I.2
Merta, A.3
Cerny, J.4
Vesely, J.5
Vlach, J.6
Sediva, K.7
Rosenberg, I.8
Otmar, M.9
Hrebabecky, H.10
Travnicek, M.11
Vonka, V.12
Snoeck, R.13
De Clercq, E.14
-
11
-
-
0026755636
-
Cellular metabolism and enzymatic phosphorylation of 9-(2- phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent
-
Ho HT, Woods KL, Konrad SA, De Boeck H and Hitchcock MJ: Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent. Adv Exp Med Biol 312: 159-166, 1992.
-
(1992)
Adv Exp Med Biol
, vol.312
, pp. 159-166
-
-
Ho, H.T.1
Woods, K.L.2
Konrad, S.A.3
De Boeck, H.4
Hitchcock, M.J.5
-
12
-
-
0014248511
-
Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County
-
Dorn CR, Taylor DO, Schneider R, Hibbard HH and Klauber MR: Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40: 307-318, 1968.
-
(1968)
J Natl Cancer Inst
, vol.40
, pp. 307-318
-
-
Dorn, C.R.1
Taylor, D.O.2
Schneider, R.3
Hibbard, H.H.4
Klauber, M.R.5
-
13
-
-
37349034010
-
Canine Lymphoma and Lymphoid Leukemia
-
Withrow SJ, Vail DM (eds.). St. Louis, Mo.: Saunders Elsevier
-
Vail DM and Young KM: Canine Lymphoma and Lymphoid Leukemia. In: Withrow & MacEwen's Small Animal Clinical Oncology. Withrow SJ, Vail DM (eds.). St. Louis, Mo.: Saunders Elsevier, pp. 699-733, 2007.
-
(2007)
Withrow & MacEwen's Small Animal Clinical Oncology
, pp. 699-733
-
-
Vail, D.M.1
Young, K.M.2
-
14
-
-
33750349768
-
Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma
-
DOI 10.1892/0891-6640(2006)20[1178:DMADCA]2.0.CO;2
-
Alvarez FJ, Kisseberth WC, Gallant SL and Couto CG: Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma. J Vet Intern Med 20: 1178-1183, 2006. (Pubitemid 44621049)
-
(2006)
Journal of Veterinary Internal Medicine
, vol.20
, Issue.5
, pp. 1178-1183
-
-
Alvarez, F.J.1
Kisseberth, W.C.2
Gallant, S.L.3
Couto, C.G.4
-
15
-
-
0033190920
-
Lomustine (CCNU) for the treatment of resistant lymphoma in dogs
-
Moore AS, London CA, Wood CA, Williams LE, Cotter SM, L'Heureux DA and Frimberger AE: Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 13: 395-398, 1999.
-
(1999)
J Vet Intern Med
, vol.13
, pp. 395-398
-
-
Moore, A.S.1
London, C.A.2
Wood, C.A.3
Williams, L.E.4
Cotter, S.M.5
L'Heureux, D.A.6
Frimberger, A.E.7
-
16
-
-
0028512653
-
Actinomycin D for reinduction of remission in dogs with resistant lymphoma
-
Moore AS, Ogilvie GK and Vail DM: Actinomycin D for reinduction of remission in dogs with resistant lymphoma. J Vet Intern Med 8: 343-344, 1994.
-
(1994)
J Vet Intern Med
, vol.8
, pp. 343-344
-
-
Moore, A.S.1
Ogilvie, G.K.2
Vail, D.M.3
-
17
-
-
0041737061
-
MOPP chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989-2000)
-
Rassnick KM, Mauldin GE, Al-Sarraf R, Mauldin GN, Moore AS and Mooney SC: MOPP chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989-2000). J Vet Intern Med 16: 576-580, 2002. (Pubitemid 135747438)
-
(2002)
Journal of Veterinary Internal Medicine
, vol.16
, Issue.5
, pp. 576-580
-
-
Rassnick, K.M.1
Mauldin, G.E.2
Al-Sarraf, R.3
Mauldin, G.N.4
Moore, A.S.5
Mooney, S.C.6
-
18
-
-
66149168682
-
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma
-
Vail DM, Thamm DH, Reiser H, Ray AS, Wolfgang GH, Watkins WJ, Babusis D, Henne IN, Hawkins MJ, Kurzman ID, Jeraj R, Vanderhoek M, Plaza S, Anderson C, Wessel MA, Robat C, Lawrence J and Tumas DB: Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clin Cancer Res 15: 3503-3510, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3503-3510
-
-
Vail, D.M.1
Thamm, D.H.2
Reiser, H.3
Ray, A.S.4
Wolfgang, G.H.5
Watkins, W.J.6
Babusis, D.7
Henne, I.N.8
Hawkins, M.J.9
Kurzman, I.D.10
Jeraj, R.11
Vanderhoek, M.12
Plaza, S.13
Anderson, C.14
Wessel, M.A.15
Robat, C.16
Lawrence, J.17
Tumas, D.B.18
-
19
-
-
0014186966
-
A novel method for phosphorylation of nucleosides to 5′-nucleotides
-
Yoshikawa M, Kato T and Takenishi T: A novel method for phosphorylation of nucleosides to 5′-nucleotides. Tetrahedron Lett 50: 5065-5068, 1967.
-
(1967)
Tetrahedron Lett
, vol.50
, pp. 5065-5068
-
-
Yoshikawa, M.1
Kato, T.2
Takenishi, T.3
-
21
-
-
43049123187
-
6-substituted purine acyclic nucleoside phosphonates
-
6-substituted purine acyclic nucleoside phosphonates. Collect Czech Chem Commun 73: 275-291, 2008.
-
(2008)
Collect Czech Chem Commun
, vol.73
, pp. 275-291
-
-
Schinkmanova, M.1
Votruba, I.2
Shibata, R.3
Han, B.4
Liu, X.5
Cihlar, T.6
Holy, A.7
-
22
-
-
0041935939
-
-
Institutes of Health, Bethesda, Maryland, USA
-
Rasband WS: ImageJ, Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2011.
-
(1997)
ImageJ
-
-
Rasband, W.S.1
-
23
-
-
0027398949
-
A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water
-
Wilson DK and Quiocho FA: A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. Biochemistry 32: 1689-1694, 1993. (Pubitemid 23066441)
-
(1993)
Biochemistry
, vol.32
, Issue.7
, pp. 1689-1694
-
-
Wilson, D.K.1
Quiocho, F.A.2
-
24
-
-
0030278180
-
Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: Sequential analysis and predictive ability in dogs with lymphoma
-
Bergman PJ, Ogilvie GK and Powers BE: Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: Sequential analysis and predictive ability in dogs with lymphoma. J Vet Intern Med 10: 354-359, 1996. (Pubitemid 126701152)
-
(1996)
Journal of Veterinary Internal Medicine
, vol.10
, Issue.6
, pp. 354-359
-
-
Bergman, P.J.1
Ogilvie, G.K.2
Powers, B.E.3
-
25
-
-
0030227521
-
Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues
-
Ginn PE: Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Vet Pathol 33: 533-541, 1996.
-
(1996)
Vet Pathol
, vol.33
, pp. 533-541
-
-
Ginn, P.E.1
-
26
-
-
0029965253
-
P-glycoprotein expression in canine lymphoma: A relevant, intermediate model of multidrug resistance
-
DOI 10.1002/(SICI)1097-0142(19960501)77:9<1892::AI
-
Lee JJ, Hughes CS, Fine RL and Page RL: P-glycoprotein expression in canine lymphoma: A relevant, intermediate model of multidrug resistance. Cancer 77: 1892-1898, 1996. (Pubitemid 26125192)
-
(1996)
Cancer
, vol.77
, Issue.9
, pp. 1892-1898
-
-
Lee, J.J.1
Hughes, C.S.2
Fine, R.L.3
Page, R.L.4
-
27
-
-
0029130028
-
The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance
-
Moore AS, Leveille CR, Reimann KA, Shu H and Arias IM: The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Invest 13: 475-479, 1995.
-
(1995)
Cancer Invest
, vol.13
, pp. 475-479
-
-
Moore, A.S.1
Leveille, C.R.2
Reimann, K.A.3
Shu, H.4
Arias, I.M.5
-
28
-
-
36849005953
-
Multidrug resistance in cancer: Its mechanism and its modulation
-
DOI 10.1358/dnp.2007.20.6.1141496
-
Pauwels EK, Erba P, Mariani G and Gomes CM: Multidrug resistance in cancer: Its mechanism and its modulation. Drug News Perspect 20: 371-377, 2007. (Pubitemid 350219069)
-
(2007)
Drug News and Perspectives
, vol.20
, Issue.6
, pp. 371-377
-
-
Pauwels, E.K.J.1
Erba, P.2
Mariani, G.3
Gomes, C.M.F.4
-
29
-
-
2442696471
-
Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia
-
DOI 10.1124/jpet.103.063966
-
Dallas S, Schlichter L and Bendayan R: Multidrug-resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. J Pharmacol Exp Ther 309: 1221-1229, 2004. (Pubitemid 38669713)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.309
, Issue.3
, pp. 1221-1229
-
-
Dallas, S.1
Schlichter, L.2
Bendayan, R.3
-
30
-
-
34250882212
-
Experimental therapy with 9-[2-(Phosphonomethoxy)ethyl]-2, 6-diaminopurine (PMEDAP): Origin of resistance
-
Zapotocky M, Hanzalova J, Starkova J, Votruba I, Holy A and Otova B: Experimental therapy with 9-[2-(phosphonomethoxy) ethyl]-2,6-diaminopurine (PMEDAP): Origin of resistance. Folia Biol 53: 79-84, 2007. (Pubitemid 46979029)
-
(2007)
Folia Biologica
, vol.53
, Issue.3
, pp. 79-84
-
-
Zapotocky, M.1
Hanzalova, J.2
Starkova, J.3
Votruba, I.4
Holy, A.5
Otova, B.6
-
31
-
-
0019376933
-
Biochemistry of diseases of immunodevelopment
-
Martin DW Jr. and Gelfand EW: Biochemistry of diseases of immunodevelopment. Annu Rev Biochem 50: 845-877, 1981.
-
(1981)
Annu Rev Biochem
, vol.50
, pp. 845-877
-
-
Martin Jr., D.W.1
Gelfand, E.W.2
-
32
-
-
28244477635
-
Phylogenetic analysis reveals a novel protein family closely related to adenosine deaminase
-
DOI 10.1007/s00239-005-0046-y
-
Maier SA, Galellis JR and McDermid HE: Phylogenetic analysis reveals a novel protein family closely related to adenosine deaminase. J Mol Evol 61: 776-794, 2005. (Pubitemid 41706026)
-
(2005)
Journal of Molecular Evolution
, vol.61
, Issue.6
, pp. 776-794
-
-
Maier, S.A.1
Galellis, J.R.2
McDermid, H.E.3
-
33
-
-
4043137442
-
Purine nucleoside antimetabolites in development for the treatment of cancer
-
Parker WB, Secrist JA, 3rd and Waud WR: Purine nucleoside antimetabolites in development for the treatment of cancer. Curr Opin Investig Drugs 5: 592-596, 2004.
-
(2004)
Curr Opin Investig Drugs
, vol.5
, pp. 592-596
-
-
Parker, W.B.1
Secrist III, J.A.2
Waud, W.R.3
-
34
-
-
18844403641
-
Nelarabine: A nucleoside analog with efficacy in T-cell and other leukemias
-
Kisor DF: Nelarabine: A nucleoside analog with efficacy in T-cell and other leukemias. Ann Pharmacother 39: 1056-1063, 2005.
-
(2005)
Ann Pharmacother
, vol.39
, pp. 1056-1063
-
-
Kisor, D.F.1
-
35
-
-
0030903443
-
Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89
-
Faletto MB, Miller WH, Garvey EP, St Clair MH, Daluge SM and Good SS: Unique intracellular activation of the potent antihuman immunodeficiency virus agent 1592U89. Antimicrob Agents Chemother 41: 1099-1107, 1997. (Pubitemid 27194192)
-
(1997)
Antimicrobial Agents and Chemotherapy
, vol.41
, Issue.5
, pp. 1099-1107
-
-
Faletto, M.B.1
Miller, W.H.2
Garvey, E.P.3
St., C.M.H.4
Daluge, S.M.5
Good, S.S.6
-
36
-
-
0023745214
-
Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts
-
Akeson AL, Wiginton DA, Dusing MR, States JC and Hutton JJ: Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts. J Biol Chem 263: 16291-16296, 1988. (Pubitemid 18262048)
-
(1988)
Journal of Biological Chemistry
, vol.263
, Issue.31
, pp. 16291-16296
-
-
Akeson, A.L.1
Wiginton, D.A.2
Dusing, M.R.3
States, J.C.4
Hutton, J.J.5
-
37
-
-
0023212149
-
Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing
-
Akeson AL, Wiginton DA, States JC, Perme CM, Dusing MR and Hutton JJ: Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing. Proc Natl Acad Sci USA 84: 5947-5951, 1987. (Pubitemid 17130423)
-
(1987)
Proceedings of the National Academy of Sciences of the United States of America
, vol.84
, Issue.16
, pp. 5947-5951
-
-
Akeson, A.L.1
Wiginton, D.A.2
States, C.3
-
38
-
-
0021816217
-
Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency
-
Bonthron DT, Markham AF, Ginsburg D and Orkin SH: Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J Clin Invest 76: 894-897, 1985. (Pubitemid 15023151)
-
(1985)
Journal of Clinical Investigation
, vol.76
, Issue.2
, pp. 894-897
-
-
Bonthron, D.T.1
Markham, A.F.2
Ginsburg, D.3
Okrin, S.H.4
-
39
-
-
0024508043
-
Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency
-
Hirschhorn R, Tzall S, Ellenbogen A and Orkin SH: Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. J Clin Invest 83: 497-501, 1989. (Pubitemid 19061169)
-
(1989)
Journal of Clinical Investigation
, vol.83
, Issue.2
, pp. 497-501
-
-
Hirschhorn, R.1
Tzall, S.2
Ellenbogen, A.3
Orkin, S.H.4
-
40
-
-
0022567152
-
One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity
-
Valerio D, Dekker BM, Duyvesteyn MG, van der Voorn L, Berkvens TM, van Ormondt H and van der Eb AJ: One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity. EMBO J 5: 113-119, 1986.
-
(1986)
EMBO J
, vol.5
, pp. 113-119
-
-
Valerio, D.1
Dekker, B.M.2
Duyvesteyn, M.G.3
Van Der Voorn, L.4
Berkvens, T.M.5
Van Ormondt, H.6
Van Der Eb, A.J.7
-
41
-
-
0026434561
-
Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutations
-
Wilson DK, Rudolph FB and Quiocho FA: Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutations. Science 252: 1278-1284, 1991. (Pubitemid 21917036)
-
(1991)
Science
, vol.252
, Issue.5010
, pp. 1278-1284
-
-
Wilson, D.K.1
Rudolph, F.B.2
Quiocho, F.A.3
|